IL6 and melanoma: This inhibitory effect was mediated by IL-6, IL-10, and VEGF and could be partially reversed by pre-treatment of the melanoma cells with BRAFV600E specific RNAi, indicating that constitutive activation of the MAPK pathway in melanoma cells may lead to compromised DC function and that this immune evasion may be overcome by MAPK inhibition.